1. Home
  2. MYNZ vs MITQ Comparison

MYNZ vs MITQ Comparison

Compare MYNZ & MITQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MYNZ
  • MITQ
  • Stock Information
  • Founded
  • MYNZ 2021
  • MITQ N/A
  • Country
  • MYNZ Germany
  • MITQ United States
  • Employees
  • MYNZ N/A
  • MITQ N/A
  • Industry
  • MYNZ Biotechnology: Pharmaceutical Preparations
  • MITQ Telecommunications Equipment
  • Sector
  • MYNZ Health Care
  • MITQ Telecommunications
  • Exchange
  • MYNZ Nasdaq
  • MITQ Nasdaq
  • Market Cap
  • MYNZ 7.9M
  • MITQ 7.6M
  • IPO Year
  • MYNZ 2021
  • MITQ 2021
  • Fundamental
  • Price
  • MYNZ $1.77
  • MITQ $0.71
  • Analyst Decision
  • MYNZ Buy
  • MITQ
  • Analyst Count
  • MYNZ 2
  • MITQ 0
  • Target Price
  • MYNZ $14.00
  • MITQ N/A
  • AVG Volume (30 Days)
  • MYNZ 180.5K
  • MITQ 60.4K
  • Earning Date
  • MYNZ 08-26-2025
  • MITQ 09-25-2025
  • Dividend Yield
  • MYNZ N/A
  • MITQ N/A
  • EPS Growth
  • MYNZ N/A
  • MITQ N/A
  • EPS
  • MYNZ N/A
  • MITQ N/A
  • Revenue
  • MYNZ $893,991.00
  • MITQ $18,613,000.00
  • Revenue This Year
  • MYNZ $26.06
  • MITQ N/A
  • Revenue Next Year
  • MYNZ $4.97
  • MITQ N/A
  • P/E Ratio
  • MYNZ N/A
  • MITQ N/A
  • Revenue Growth
  • MYNZ N/A
  • MITQ N/A
  • 52 Week Low
  • MYNZ $1.30
  • MITQ $0.50
  • 52 Week High
  • MYNZ $18.40
  • MITQ $1.55
  • Technical
  • Relative Strength Index (RSI)
  • MYNZ 53.56
  • MITQ 47.46
  • Support Level
  • MYNZ $1.41
  • MITQ $0.62
  • Resistance Level
  • MYNZ $1.76
  • MITQ $0.75
  • Average True Range (ATR)
  • MYNZ 0.16
  • MITQ 0.05
  • MACD
  • MYNZ 0.02
  • MITQ -0.01
  • Stochastic Oscillator
  • MYNZ 68.12
  • MITQ 50.06

About MYNZ Mainz Biomed N.V.

Mainz Biomed NV develops market-ready molecular genetic diagnostic solutions for life-threatening conditions. The company's flagship product is ColoAlert, is an accurate, non-invasive and easy-to-use, early-detection diagnostic test for colorectal cancer based on real-time Polymerase Chain Reaction-based (PCR) multiplex detection of molecular-genetic biomarkers in stool samples. The company operates in one operating segment, genetic diagnostic testing.

About MITQ Moving iMage Technologies Inc.

Moving iMage Technologies Inc is engaged in providing designed equipment as well as other off the shelf cinema products needed for contemporary cinema requirements. It offers technical, design and consulting services such as custom engineering, systems design, integration and installation and digital technology, as well as software solutions for operations enhancement and theatre management.

Share on Social Networks: